Anti-VEGF Biosimilars for nAMD
A promising alternative to traditional neovascular age-related macular degeneration therapies? The emergence of anti-vascular endothelial growth factor (anti-VEGF) biosimilars offers…
A promising alternative to traditional neovascular age-related macular degeneration therapies? The emergence of anti-vascular endothelial growth factor (anti-VEGF) biosimilars offers…